PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: in vitro and in vivo studies
Marcelle Silva-Abreu,1,2 Ana Cristina Calpena,1,2 Pol Andrés-Benito,3,4 Ester Aso,3,4 Ignacio A Romero,5 David Roig-Carles,5 Radka Gromnicova,5 Marta Espina,1,2 Isidre Ferrer,3,4 María Luisa García,1,2 David Male5 1Department of Pharmacy, Pharmaceutical Technology a...
Enregistré dans:
Auteurs principaux: | Silva-Abreu M, Calpena AC, Andrés-Benito P, Aso E, Romero IA, Roig-Carles D, Gromnicova R, Espina M, Ferrer I, García ML, Male D |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2417f5fa9d024b44a02f84dea736322c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells
par: Shadi Esmaeili, et autres
Publié: (2021) -
Participation of nitrogen oxide and its metabolites in the genesis of hyperimmune inflammation in COVID-19
par: Sergey Petrovich Lysenkov, et autres
Publié: (2021) -
CD4+ effector T cells accelerate Alzheimer’s disease in mice
par: Jatin Machhi, et autres
Publié: (2021) -
Transcriptome Profile During Rabies Virus Infection: Identification of Human CXCL16 as a Potential New Viral Target
par: Lena Feige, et autres
Publié: (2021) -
Stabilization by Nano Spray Dryer of Pioglitazone Polymeric Nanosystems: Development, In Vivo, Ex Vivo and Synchrotron Analysis
par: Marcelle Silva-Abreu, et autres
Publié: (2021)